Common metabolic drug helps memory in mice

Share this article:
A drug that has until now been prescribed to treat patients with a certain metabolic disorder has been found to improve the memory of laboratory animals with Alzheimer's disease, according to a recent report.

Sodium phenylbutyrate is commonly used to treat patients who experience an alteration in the urea cycle. Researchers discovered that the drug also helped certain proteins, which are responsible for neuron connections, fuse together, resulting in improved learning capacity of lab mice. Researchers at the Center for Applied Medical Research (CIMA) at the University of Navarra are investigating which element of the drug is responsible for the beneficial effects.

Because sodium phenylbutyrate is already available for use, researchers suggest it could potentially be used to treat Alzheimer's and other dementia patients much sooner than other experimental drugs. The report was published in the journal Neuropsychopharmacology.
Share this article:

More in News

$1.3 million settlement marks second recent deal over SNF supervision of therapy providers

$1.3 million settlement marks second recent deal over ...

A Maryland nursing home company has agreed to a $1.3 million settlement over charges that it did not prevent overbilling by its contracted therapy provider, federal authorities announced Monday. This ...

MedPAC chairman: Three-day stay requirement is 'archaic'

The government should pay for skilled nursing care without a preliminary three-day hospital stay, and the recovery auditor program should be reformed, Medicare Payment Advisory Commission members said at a meeting Friday.

Nursing homes can't carve out billing, collections in arbitration agreements, AR Supreme ...

A nursing home arbitration agreement largely reserved the provider's rights to sue residents while limiting residents' legal options, causing it to fail a "mutual obligation" requirement, the Arkansas Supreme Court recently ruled .